by Jignyasa Bal | Jun 24, 2026 | In Silico & Data Insights, In Silico Insider, Leadscope
Introduction Extractables and leachables (E&Ls) represent a critical class of drug product impurities originating from materials used in manufacturing systems, packaging, and delivery devices. These compounds have the potential to migrate into drug products and...
by Jignyasa Bal | Jun 22, 2026 | NOTOCORD-hem, Study Management
NOTOCORD‑hem 5.3 builds on the established NOTOCORD‑hem software, introducing new analytical modules and performance improvements to support advanced physiological research. The platform continues to provide a comprehensive environment for the acquisition, analysis,...
by Jignyasa Bal | Apr 28, 2026 | In Silico & Data Insights, In Silico Insider, Leadscope, Press Releases
Leadscope Model Applier™ is the industry standard for in silico toxicology predictions, trusted by pharmaceutical developers, chemical safety teams, and regulators worldwide. With the v2026 release, we are delivering broader coverage, deeper insights, and enhanced...
by Jignyasa Bal | Jan 21, 2026 | NOTOCORD-hem, Study Management
NOTOCORD-hem is a comprehensive, GLP-compliant software platform for assessing physiological functions across cardiovascular, respiratory, and nervous system applications in nonclinical and life science academic research. With more than 160 advanced modules, the...
by Jignyasa Bal | Dec 1, 2025 | NOTOCORD-hem, Study Management
Safety pharmacology is a demanding yet critical phase of early drug development. It requires accuracy to ensure actionable insights and translatability, as well as efficiency to meet competitive timelines. ICH guidelines require a comprehensive battery of tests across...
